Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: Implicating fat in pancreatic pathology

Pancreatology

Volumn 9, Issue 4, 2009, Pages 410-419

  Zyromski, Nicholas J ^a   Mathur, Abhishek ^a   Gowda, G A Nagana ^b   Murphy, Carl ^b   Swartz Basile, Deborah A ^a   Wade, Terence E ^a   Pitt, Henry A ^a   Raftery, Daniel ^b  

^a INDIANA UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Inflammation; Metabolomics; Obesity; Pancreatic cancer; Pancreatitis

Indexed keywords

FAT; FATTY ACID; LEPTIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FAT CONTENT; FEMALE; GAS CHROMATOGRAPHY; LEAN BODY WEIGHT; METABOLOME; METABOLOMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PANCREAS; PANCREAS CANCER; PANCREAS DISEASE; PANCREATITIS; PATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; THIN LAYER CHROMATOGRAPHY;

EID: 65649099171     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000199436     Document Type: Article

References (43)

1. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43:S99-S112.
2. Goldblatt MI, Swartz-Basile DA, Al-Azzawi HH, Tran KQ, Nakeeb A, Pitt HA: Nonalcoholic fatty gallbladder disease: the influence of diet in lean and obese mice. J Gastrointest Surg 2006; 10:193-201.
3. Mathur A, Murine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, Pitt HA: Nonalcoholic fatty pancreas disease. HPB 2007; 9:312-318.
4. Schaffer JE: Lipotoxitcity: when tissues overeat. Curr Opin Lipidol 2003; 14 : 281-287.
5. Greenberg AS, Obin MS: Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 20 06; 83: 461S- 465S.
6. Weisberg SP, McCann D, Desai M, Rosen-baum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796 -1808.
7. McCullough AJ: Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006; 40:S17-S29.
8. DeWaele B, Vanmierlo B, Van Nieuwenhove Y, Delvaux G: Impact of body overweight and class I, II and III obesity on the outcome of acute biliary pancreatitis. Pancreas 2006; 32:343-345.
9. Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Perez-Mateo M: Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006; 6: 206-209.
10. Papachristou GI, Papachristou DJ, Avula H, Slivka A, Whitcomb DC: Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancre-atology 2006; 6: 279-285.
11. Suazo-Barahona J, Carmona-Sanchez R, Ro-bles-Diaz G, Milke-Garcia P, Vargas-Vo-rackova F, Uscanga-Dominguez L, Pelaez-Luna M: Obesity: a risk factor for severe acute biliary and alcoholic pancreatitis. Am J Gastroenterol 1998; 93:1324-1328.
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.
13. Giovannucci E, Michaud D: The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132:2208-2225.
14. Michaud DS, Giovannucci E, Willet WC, Colditz GA, Stampfer MJ, Fuchs CS: Physical activity, obesity, height and the risk of pancreatic cancer. JAM A 2001; 286: 921-929.
15. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE: Obesity, recreational physical activity, and the risk of pancreatic cancer in a large US cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 459-466.
16. Zyromski NJ, Mathur A, Yancey K, Gripe JT, Walker JJ, Lu D, Swartz-Basile DA, Lillemoe KD, Pitt HA: A murine model of obesity implicates the adipokine milieu in the patho-genesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008; 295: G552-G558.
17. Griffin JL, Nicholls AW: Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 2006; 7: 1095-1107.
18. Lindon JC, Holmes E, Nicholson JK: Metab-olomics techniques and applications to pharmaceutical research and development. Pharm Res 1006; 23:1075-1088.
19. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagare-tani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y: Adiponectin specifically increased tissue inhibitor of me-talloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109:2046-2049.
20. Lee JE, Choi SY, Huh W, Kim YG, Kim DJ, Oh HY: Metabolic syndrome, C-reactive protein, and chronic kidney disease in non-diabetic, nonhypertensive adults. Am J Hy-pertens 2007; 20:1189-1194.
21. Ogilvie RF: The islands of Langerhans in 19 cases of obesity. J Pathol Bacteriol 1933; 37: 473 - 481.
22. Olsen TS: Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Microbiol Scand Sect A 1978; 86: 367-373.
23. Kovanlikaya A, Mittelman SD, Ward A, Geffner ME, Dorey F, Gilsanz V: Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 2005; 35:601-607.
24. Matsumoto S, Mori H, Miyake H, Takaki H, Maeda T, Yamada Y, Oga M: Uneven fatty replacement of the pancreas: evaluation with CT. Radiolog y 1995; 19 4: 453-458.
25. Mathur A, Pitt HA, Maxine M, Saxena R, Schmidt CM, Howard TJ, Nakeeb A, Zyrom-ski NJ, Lillemoe KD: Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 2007; 246:1058-1064.
26. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 25p:87-91.
27. Hirata T, Unoki H, Bujo H, Ueno K, Saito Y: Activation of diacylglycerol O-acyltransfer-ase 1 gene results in increased tumor necrosis factor-alpha gene expression in 3T3-L1 adipoc y tes. FEBS Lett 2006; 580: 5117- 51 21.
28. Cha MC, Chou CJ, Boozer CN: High-fat diet feeding reduces the diurnal variation of plasma leptin concentration in rats. Metabolism 2000; 49: 503-507.
29. Fernandez-Real JM, Broch M, Vendrell J, Ri-card W: Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003; 26:1362-1368.
30. Lovejoy JC, Windhauser MM, Rood JC, de la Bretonne JA: Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women. Metabolism 1998; 47: 1520 - 1524.
31. Nguyen MT, Satoh H, Favelyukis S, Baben-dure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi NW, Olefsky JM: JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L2 ad-ipocy tes. J Biol Chem 2005; 280: 35361-35371.
32. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17:4-12.
33. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderan N: Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005; 54:3458-3465.
34. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P: Circulating mono-nuclear cells in the obese are in a proinflam-mator y state. Circulation 2004; 110: 1564- 1571.
35. Suganami T, Nishida J, Ogawa Y: A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha . Arterioscler Th romb Vasc Biol 2005; 25: 2062-2068.
36. Inoguchi T, LiP, Umeda F, Yu H Y, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acids stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-1945.
37. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS: Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003; 88: 17 3 0 -17 3 6 .
38. Beger RD, Schnackenberg LK, Holland RD, Li D, Dragan Y: Metabolomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolo-mics 2006; 2: 125 -134.
39. 1H nuclear magnetic resonance and principal components analysis. Cancer Sci 2007; 98:1678-1682 .
40. 13C NMR. Proc Natl Acad Sci USA 2007; 104:11540-11544.
41. Chen HW, Pan Z, Talaty N, Cooks RG, Raftery D: Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabo-lomics without sample preparation. Rapid Commun Mass Spectrom 2006; 20: 1577- 1584.
42. Gu H, Chen H, Pan Z, Jackson AU, Talaty N, Xi B, Kissinger C, Duda C, Mann D, Raftery D, Cooks RG: Monitoring diet effects from biofluids and their implications for metabo-lomics studies. Anal Chem 2007; 79:89-97.
43. Pan Z, Raftery D: Combining NMR spec-troscopy and mass spectrometry in metabo-lomics. Anal Bioanal Chem 2007; 387:525- 527.